Current Report Filing (8-k)
August 30 2016 - 4:45PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 30, 2016
CEMPRA, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-35405
|
|
45-4440364
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
ID Number)
|
|
|
|
6320 Quadrangle Drive, Suite 360, Chapel Hill, NC
|
|
27517
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code (919) 313-6601
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
On August 30, 2016, we issued a press release announcing that the U.S. Food and Drug Administration has scheduled a meeting of the Antimicrobial Drugs
Advisory Committee on November 4, 2016 in Silver Spring, Maryland to discuss the safety and efficacy of solithromycin to treat community-acquired bacterial pneumonia. A copy of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press release dated August 30, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
CEMPRA, INC.
|
|
|
Date: August 30, 2016
|
|
/s/ Mark W. Hahn
|
|
|
Mark W. Hahn, Chief Financial Officer
|
Cempra (NASDAQ:CEMP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cempra (NASDAQ:CEMP)
Historical Stock Chart
From Sep 2023 to Sep 2024